Your browser doesn't support javascript.
loading
COVID-19 vaccine coverage targets to inform reopening plans in a low incidence setting.
Conway, Eamon; Walker, Camelia R; Baker, Christopher; Lydeamore, Michael J; Ryan, Gerard E; Campbell, Trish; Miller, Joel C; Rebuli, Nic; Yeung, Max; Kabashima, Greg; Geard, Nicholas; Wood, James; McCaw, James M; McVernon, Jodie; Golding, Nick; Price, David J; Shearer, Freya M.
Afiliación
  • Conway E; Population Health and Immunity Division, WEHI, Parkville 3052, Vic, Australia.
  • Walker CR; School of Mathematics and Statistics, The University of Melbourne, Melbourne, Victoria, Australia.
  • Baker C; School of Mathematics and Statistics, The University of Melbourne, Melbourne, Victoria, Australia.
  • Lydeamore MJ; Melbourne Centre for Data Science, The University of Melbourne, Melbourne, Victoria, Australia.
  • Ryan GE; Centre of Excellence for Biosecurity Risk Analysis, The University of Melbourne, Melbourne, Victoria, Australia.
  • Campbell T; Department of Econometrics and Business Statistics, Monash University, Clayton, Victoria, Australia.
  • Miller JC; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
  • Rebuli N; Infectious Disease Ecology and Modelling, Telethon Kids Institute, Perth, Western Australia, Australia.
  • Yeung M; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
  • Kabashima G; Department of Infectious Diseases, The University of Melbourne, Melbourne, Victoria, Australia.
  • Geard N; Department of Mathematics and Statistics, La Trobe University, Melbourne, Victoria, Australia.
  • Wood J; School of Population Health, The University of New South Wales, Sydney, New South Wales, Australia.
  • McCaw JM; Quantium, Sydney, New South Wales, Australia.
  • McVernon J; Quantium, Sydney, New South Wales, Australia.
  • Golding N; School of Computing and Information Systems, The University of Melbourne, Melbourne, Victoria, Australia.
  • Price DJ; School of Population Health, The University of New South Wales, Sydney, New South Wales, Australia.
  • Shearer FM; School of Mathematics and Statistics, The University of Melbourne, Melbourne, Victoria, Australia.
Proc Biol Sci ; 290(2005): 20231437, 2023 08 30.
Article en En | MEDLINE | ID: mdl-37644838
Since the emergence of SARS-CoV-2 in 2019 through to mid-2021, much of the Australian population lived in a COVID-19-free environment. This followed the broadly successful implementation of a strong suppression strategy, including international border closures. With the availability of COVID-19 vaccines in early 2021, the national government sought to transition from a state of minimal incidence and strong suppression activities to one of high vaccine coverage and reduced restrictions but with still-manageable transmission. This transition is articulated in the national 're-opening' plan released in July 2021. Here, we report on the dynamic modelling study that directly informed policies within the national re-opening plan including the identification of priority age groups for vaccination, target vaccine coverage thresholds and the anticipated requirements for continued public health measures-assuming circulation of the Delta SARS-CoV-2 variant. Our findings demonstrated that adult vaccine coverage needed to be at least 60% to minimize public health and clinical impacts following the establishment of community transmission. They also supported the need for continued application of test-trace-isolate-quarantine and social measures during the vaccine roll-out phase and beyond.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 4_TD Problema de salud: 1_doencas_nao_transmissiveis / 1_medicamentos_vacinas_tecnologias / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_pneumonia Asunto principal: Vacunas contra la COVID-19 / COVID-19 Tipo de estudio: Incidence_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Humans País/Región como asunto: Oceania Idioma: En Revista: Proc Biol Sci Asunto de la revista: BIOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Australia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 4_TD Problema de salud: 1_doencas_nao_transmissiveis / 1_medicamentos_vacinas_tecnologias / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_pneumonia Asunto principal: Vacunas contra la COVID-19 / COVID-19 Tipo de estudio: Incidence_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Humans País/Región como asunto: Oceania Idioma: En Revista: Proc Biol Sci Asunto de la revista: BIOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Australia
...